TickerFactsScreenerDevelopers

Aclaris Therapeutics, Inc. (ACRS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $19.04M2013: $9.59M2014: $10.76M2015: $9.85M2016: $30.17M2017: $20.20M2019: $34.19M2020: $22.06M2021: $27.35M2022: $45.28M2023: $39.88M2024: $24.57M2025: $19.96M$19.96M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$19.96M-18.8%
2024$24.57M-38.4%
2023$39.88M-11.9%
2022$45.28M+65.6%
2021$27.35M+24.0%
2020$22.06M-35.5%
2019$34.19M—
2017$20.20M-33.0%
2016$30.17M+206.3%
2015$9.85M-8.4%
2014$10.76M+12.2%
2013$9.59M-49.7%
2012$19.04M—